Company: DVAX
Filing Date: 2025-04-15
Form Type: PRER14A
Source: 0000930413-25-001254
Chunk: 47

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-15
Form: PRER14A
Chunk 47
---
 Rule 16a-1(f)                                       
 of the Exchange Act: i) annual base salary levels; ii) annual incentive compensation levels; iii) long-term incentive compensation 
 levels; and iv) employment agreements, severance agreements, change of control agreements/provisions and any other compensatory    
 arrangements, in each case as, when and if appropriate;                                                                            |
| • | make regular reports to the Board; and                                                                                             |
| • | perform such other functions and have such other powers consistent with the Compensation Committee Charter, the Company’s          
 Amended and Restated Bylaws and governing laws as the Compensation Committee or the Board may deem appropriate.                    |

Under its charter, our Compensation Committee may form, and delegate authority to, subcommittees, as appropriate.
Our Compensation Committee has authorized and delegated authority to our Chief Executive Officer to grant stock options to employees
and consultants who are not officers of the Company from pre-approved pools and in accordance with guidelines designated for new
hire and annual grants. The purpose of this delegation is to enhance the flexibility of option administration within the Company
and to facilitate the timely grant of options to non-executive employees, particularly new employees, within specified limits
and values approved by our Compensation Committee.

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

None of the members of our Compensation Committee at any time has been one of our officers or employees or
an officer or employee of one of our subsidiaries at any time during the fiscal year ended December 31, 2024. None of our
executive officers currently serve, or in the past year has served, as a member of the board of directors or compensation committee
of any entity that has one or more executive officers on our Board or Compensation Committee.

NOMINATING AND CORPORATE GOVERNANCE COMMITTEE

For 2024, our Nominating and Corporate Governance Committee was composed of three independent directors:
Drs. Kisner (Chairperson) and Cano and Mr. MacGregor.

The Nominating and Corporate Governance Committee operates under a written charter that is available to stockholders
on the Company’s website at https://investors.dynavax.com/corporate-governance.

Among other things, the charter specifically requires the Nominating and Corporate Governance Committee to:
establish criteria for Board qualification and membership;

| • | Identify, review, evaluate and recommend candidates to serve as directors of the Company;                                 |
| • | review, evaluate and recommend incumbent directors for nomination for reelection;